Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis
Jack Leslie, … , Derek A. Mann, Lee A. Borthwick
Jack Leslie, … , Derek A. Mann, Lee A. Borthwick
Published February 27, 2020
Citation Information: JCI Insight. 2020;5(4):e125937. https://doi.org/10.1172/jci.insight.125937.
View: Text | PDF
Research Article Cell biology Immunology

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis

  • Text
  • PDF
Abstract

Neutrophils are the most abundant inflammatory cells at the earliest stages of wound healing and play important roles in wound repair and fibrosis. Formyl peptide receptor 1 (FPR-1) is abundantly expressed on neutrophils and has been shown to regulate their function, yet the importance of FPR-1 in fibrosis remains ill defined. FPR-1–deficient (fpr1–/–) mice were protected from bleomycin-induced pulmonary fibrosis but developed renal and hepatic fibrosis normally. Mechanistically, we observed a failure to effectively recruit neutrophils to the lungs of fpr1–/– mice, whereas neutrophil recruitment was unaffected in the liver and kidney. Using an adoptive transfer model we demonstrated that the defect in neutrophil recruitment to the lung was intrinsic to the fpr1–/– neutrophils, as C57BL/6 neutrophils were recruited normally to the damaged lung in fpr1–/– mice. Finally, C57BL/6 mice in which neutrophils had been depleted were protected from pulmonary fibrosis. In conclusion, FPR-1 and FPR-1 ligands are required for effective neutrophil recruitment to the damaged lung. Failure to recruit neutrophils or depletion of neutrophils protects from pulmonary fibrosis.

Authors

Jack Leslie, Ben J.M. Millar, Alicia del Carpio Pons, Rachel A. Burgoyne, Joseph D. Frost, Ben S. Barksby, Saimir Luli, Jon Scott, A. John Simpson, Jack Gauldie, Lynne A. Murray, Donna K. Finch, Alan M. Carruthers, John Ferguson, Matthew A. Sleeman, David Rider, Rachel Howarth, Christopher Fox, Fiona Oakley, Andrew J. Fisher, Derek A. Mann, Lee A. Borthwick

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 6 11 11 3 9 5 45
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (45)

Title and authors Publication Year
RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition.
Fang Y, Chung SSW, Xu L, Xue C, Liu X, Jiang D, Li R, Korogi Y, Yuan K, Saqi A, Hibshoosh H, Huang Y, Lin CS, Tsukui T, Sheppard D, Sun X, Que J
Nature 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis.
Margraf A, Chen J, Christoforou M, Claria-Ribas P, Henriques Schneider A, Cecconello C, Bu W, Imbert PRC, Wright TD, Russo S, Blacksell IA, Koenis DS, Dalli J, Lupisella JA, Wurtz NR, Garcia RA, Cooper D, Norling LV, Perretti M
EMBO molecular medicine 2025
Wound repair and immune function in the Pseudomonas infected CF lung: before and after highly effective modulator therapy.
Matthews EL, Hirsch MJ, Prokopczuk F, Jones LI, Martínez E, Barnes JW, Krick S
Frontiers in cellular and infection microbiology 2025
Periodontitis aggravates pulmonary fibrosis by Porphyromonas gingivalis-promoted infiltration of neutrophils and Th17 cells
Ye HL, Meng XQ, Li H, Sun X, Lin WZ, Zhou LJ, Zhang J, Hou C, Xu S, Chen BY, Qiu C, Li YL, Wang YL, Yan LF, Duan SZ
Frontiers in Cellular and Infection Microbiology 2025
Let-7b-5p loaded Mesenchymal Stromal Cell Extracellular Vesicles reduce Pseudomonas-biofilm formation and inflammation in CF Bronchial Epithelial Cells
Sarkar S, Barnaby R, Nymon A, Charpentier LA, Taub L, Wargo MJ, Weiss DJ, Bonfield TL, Stanton BA
bioRxiv 2025
Temporal dichotomy of neutrophil function in acute liver injury and repair
Cartwright JA, Potey PM, Livingstone E, Campana L, Starkey Lewis PJ, Oremek ME, Gachanja NN, Rinaldi G, Aird RE, Man TY, Fernando AJ, Simpson JP, Homer NZ, Barth N, Addison M, Ashmore-Harris C, Candela ME, Kilpatrick AM, Vermeren M, Robb CT, Dorward DA, Lucas CD, Forbes SJ, Rossi AG
JHEP Reports 2025
Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease
McAllister MJ, Hall R, Whelan RJ, Fischer LJ, Chuah CS, Cartlidge PD, Drury B, Rutherford DG, Duffin RM, Cartwright JA, Dorward DA, Rossi AG, Ho GT
2024
Molecular mechanisms underlying the therapeutic effects of Linggui Zhugan decoction in stroke: Insights from network pharmacology and single-cell transcriptomics analysis
Sun D, Luo F, Fang C, Zhu Q, Li C
Medicine 2024
Unveiling Atherosclerotic Plaque Heterogeneity and SPP1+/VCAN+ Macrophage Subtype Prognostic Significance Through Integrative Single-Cell and Bulk-Seq Analysis
Xu X, Qiu F, Yang M, Liu X, Tao S, Zheng B
Journal of inflammation research 2024
Differential requirement of Formyl Peptide Receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection
Nafiz TN, Sankar P, Mishra LK, Rousseau RP, Saqib M, Subbian S, Parihar SP, Mishra BB
Research square 2024
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Wang J, Li K, Hao D, Li X, Zhu Y, Yu H, Chen H
MedComm 2024
Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection.
Nafiz TN, Sankar P, Mishra LK, Rousseau RP, Saqib M, Subbian S, Parihar SP, Mishra BB
Scientific reports 2024
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis
Zhao AY, Unterman A, Abu Hussein NS, Sharma P, Nikola F, Flint J, Yan X, Adams TS, Justet A, Sumida TS, Zhao J, Schupp JC, Raredon MS, Ahangari F, Deluliis G, Zhang Y, Buendia-Roldan I, Adegunsoye A, Sperling AI, Prasse A, Ryu C, Herzog E, Selman M, Pardo A, Kaminski N
American Journal of Respiratory and Critical Care Medicine 2024
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives
Crowley LE, Stockley RA, Thickett DR, Dosanjh D, Scott A, Parekh D
European Respiratory Review 2024
Integration of Microarray Data and Single-Cell Sequencing Analysis to Explore Key Genes Associated with Macrophage Infiltration in Heart Failure
Rao J, Wang X, Wang Z
Journal of Inflammation Research 2024
Targeting mitochondrial transfer: a new horizon in cardiovascular disease treatment
Zuo B, Li X, Xu D, Zhao L, Yang Y, Luan Y, Zhang B
Journal of Translational Medicine 2024
A novel biomarker of COVI-19: MMP8 emerged by integrated bulk RNAseq and single-cell sequencing
Liu Z, Wang S
Scientific Reports 2024
Editorial: Impact of tumor microenvironment on lung cancer
Levantini E
Frontiers in Oncology 2023
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
Carbonnier V, Le Naour J, Bachelot T, Vacchelli E, André F, Delaloge S, Kroemer G
OncoImmunology 2023
Novel insight into the underlying dysregulation mechanisms of immune cell-to-cell communication by analyzing multitissue single-cell atlas of two COVID-19 patients.
Qin S, Yao X, Li W, Wang C, Xu W, Gan Z, Yang Y, Zhong A, Wang B, He Z, Wu J, Wu Q, Jiang W, Han Y, Wang F, Wang Z, Ke Y, Zhao J, Gao J, Qu L, Jin P, Guan M, Xia X, Bian X
Cell Death and Disease 2023
ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion.
Wang F, Peters R, Jia J, Mudd M, Salemi M, Allers L, Javed R, Duque TLA, Paddar MA, Trosdal ES, Phinney B, Deretic V
Developmental Cell 2023
Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19
Kuley R, Duvvuri B, Wallin JJ, Bui N, Adona MV, O\u2019Connor NG, Sahi SK, Stanaway IB, Wurfel MM, Morrell ED, Liles WC, Bhatraju PK, Lood C
Virulence 2023
The Transcriptional Landscape of Pericytes in Acute Ischemic Stroke.
Buizza C, Enström A, Carlsson R, Paul G
Translational Stroke Research 2023
Immunology of human fibrosis.
Bhattacharya M, Ramachandran P
Nature Immunology 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Le Naour J, Montégut L, Pan Y, Scuderi SA, Cordier P, Joseph A, Sauvat A, Iebba V, Paillet J, Ferrere G, Brechard L, Mulot C, Dubourg G, Zitvogel L, Pol JG, Vacchelli E, Puig PL, Kroemer G
OncoImmunology 2023
Integrated bioinformatics analysis of differentially expressed genes in the temporomandibular joint internal derangement
Yang J
Clinical and Experimental Dental Research 2023
SIRT3 Regulates the ROS-FPR1/HIF-1α Axis under Hypoxic Conditions to Influence Lung Cancer Progression.
Huang B, Ding J, Guo H, Wang H, Xu J, Zheng Q, Zhou L
Cell Biochemistry and Biophysics 2023
Dynamic Evolution of Bacterial Ligand Recognition by Formyl Peptide Receptors
Paterson NM, Al-Zubieri H, Ragona J, Kohler KM, Tirado J, Geisbrecht BV, Barber MF
Genome Biology and Evolution 2023
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
R Kuley, R Stultz, B Duvvuri, T Wang, M Fritzler, R Hesselstrand, J Nelson, C Lood
Frontiers in immunology 2022
Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis
L Yin, W Zhang, D Pu, X Zhai, Y Lin, Q Wu, T Chang, J Hu, Y Li, Q Zhou
Frontiers in Oncology 2022
Fibrotic Lung Disease Alters Neutrophil Trafficking and Promotes Neutrophil Elastase and Extracellular Trap Release
Warheit-Niemi HI, Huizinga GP, Edwards SJ, Wang Y, Murray SK, O\u2019Dwyer DN, Moore BB
ImmunoHorizons 2022
Regulatory mechanisms of neutrophil migration from the circulation to the airspace
WC Lin, MB Fessler
Cellular and Molecular Life Sciences 2021
The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis
S Bolourani, M Brenner, P Wang
Journal of Molecular Medicine 2021
New Pharmacological Tools to Target Leukocyte Trafficking in Lung Disease
KB Belchamber, MJ Hughes, DA Spittle, EM Walker, E Sapey
Frontiers in immunology 2021
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
C Giacomelli, R Piccarducci, L Marchetti, C Romei, C Martini
Biochemical Pharmacology 2021
Neutrophils—From Bone Marrow to First-Line Defense of the Innate Immune System
R Kraus, M Gruber
Frontiers in immunology 2021
A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis
H Keum, D Kim, J Kim, TW Kim, CH Whang, W Jung, S Jon
Biomaterials 2021
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
X Zhao, H Li, S Lyu, J Zhai, Z Ji, Z Zhang, X Zhang, Z Liu, H Wang, J Xu, H Fan, J Kou, L Li, R Lang, Q He
International journal of biological sciences 2021
Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways
J Zhang, T Ding, D Tang, J Wang, P Huang
Experimental biology and medicine (Maywood, N.J.) 2021
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
Z Sztupinszki, JL Naour, E Vacchelli, P Laurent-Puig, S Delaloge, Z Szallasi, G Kroemer
OncoImmunology 2021
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
R Malaviya, HM Kipen, R Businaro, JD Laskin, DL Laskin
Toxicology and Applied Pharmacology 2020
The Roles of Immune Cells in the Pathogenesis of Fibrosis
E Huang, N Peng, F Xiao, D Hu, X Wang, L Lu
International journal of molecular sciences 2020
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
CC Chiang, M Korinek, WJ Cheng, TL Hwang
Frontiers in pharmacology 2020
The ambiguous role of FPR1 in immunity and inflammation
E Vacchelli, JL Naour, G Kroemer
OncoImmunology 2020
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
A Petrazzuolo, JL Naour, E Vacchelli, P Gaussem, S Ellouze, G Jourdi, E Solary, M Fontenay, DM Smadja, G Kroemer
OncoImmunology 2020

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts